Skip to main content
SpringerLink
Log in

Genistein ameliorates inflammation and insulin resistance through mediation of gut microbiota composition in type 2 diabetic mice

  • Original Contribution
  • Published:
European Journal of Nutrition Aims and scope Submit manuscript

Abstract

Purpose

Genistein (GEN) has been reported to have diverse biological activities, including antioxidant, hypolipidemic, and antidiabetic effects. This study investigated whether the ameliorative effects of GEN on inflammation and insulin resistance were associated with the modulation of gut microbiota composition in type 2 diabetic (T2D) mice.

Methods

C57BL/6J mice were treated with a high-fat diet/streptozotocin to induce T2D and then gavaged with GEN (20 and 40 mg/kg) for 8 weeks. Then, oral glucose tolerance, fasting blood glucose, serum insulin, glucagon, lipid profiles, and pro-inflammatory factors were measured. After this, hepatic function and histopathological analysis and inflammation-related indices of the liver and colon were determined, along with short-chain fatty acid (SCFA) and gut microbiota composition.

Results

GEN treatment decreased hyperglycemia, hyperlipidemia, and serum pro-inflammatory factor levels and attenuated hepatic dysfunction, pathological changes, inflammation-related protein expression, and hepatocyte apoptosis. It also ameliorated colonic pathological changes, tight junction-associated protein expression, and pro-inflammatory factor increases. Furthermore, high-dose GEN treatment increased the concentrations of SCFAs and down-regulated the ratio of Firmicutes/Bacteroidetes and the abundance of Proteobacteria at the phylum level. However, GEN increased the abundances of Bacteroides and Prevotella and decreased the levels of Helicobacter and Ruminococcus at the genus level in T2D mice.

Conclusion

GEN showed ameliorative effects on glucose and lipid dysmetabolism and hepatic and colonic dysfunction; most importantly, GEN could ameliorate inflammation and insulin resistance through modulation of gut microbiota composition.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Li BY, Xu XY, Gan RY, Sun QC, Meng JM, Shang A, Mao QQ, Li HB (2019) Targeting gut microbiota for the prevention and management of diabetes mellitus by dietary natural products. Foods 8(10):440. https://doi.org/10.3390/foods8100440

    Article  CAS  PubMed Central  Google Scholar 

  2. Laakso M (2019) Biomarkers for type 2 diabetes. Mol Metab 27S:S139–S146. https://doi.org/10.1016/j.molmet.2019.06.016

    Article  CAS  PubMed  Google Scholar 

  3. Wang Q, Zhou J, Xiang Z, Tong Q, Pan J, Wan L, Chen J (2019) Anti-diabetic and renoprotective effects of Cassiae Semen extract in the streptozotocin-induced diabetic rats. J Ethnopharmacol 239:111904. https://doi.org/10.1016/j.jep.2019.111904

    Article  PubMed  Google Scholar 

  4. Davegardh C, Garcia-Calzon S, Bacos K, Ling C (2018) DNA methylation in the pathogenesis of type 2 diabetes in humans. Mol Metab 14:12–25. https://doi.org/10.1016/j.molmet.2018.01.022

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Czech MP (2017) Insulin action and resistance in obesity and type 2 diabetes. Nat Med 23(7):804–814. https://doi.org/10.1038/nm.4350

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Jia L, Li D, Feng N, Shamoon M, Sun Z, Ding L, Zhang H, Chen W, Sun J, Chen YQ (2017) A.nti-diabetic effects of Clostridium butyricum CGMCC0313.1 through promoting the growth of gut butyrate-producing bacteria in type 2 diabetic mice. Sci Rep 7(1):7046. https://doi.org/10.1038/s41598-017-07335-0

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Tilg H, Moschen AR (2014) Microbiota and diabetes: an evolving relationship. Gut 63(9):1513–1521. https://doi.org/10.1136/gutjnl-2014-306928

    Article  CAS  PubMed  Google Scholar 

  8. Greenfield JR, Campbell LV (2006) Relationship between inflammation, insulin resistance and type 2 diabetes: “cause or effect”? Curr Diabetes Rev 2(2):195–211. https://doi.org/10.2174/157339906776818532

    Article  CAS  PubMed  Google Scholar 

  9. Koh A, De Vadder F, Kovatcheva-Datchary P, Backhed F (2016) From dietary fiber to host physiology: short-chain fatty acids as key bacterial metabolites. Cell 165(6):1332–1345. https://doi.org/10.1016/j.cell.2016.05.041

    Article  CAS  PubMed  Google Scholar 

  10. Macfarlane GT, Macfarlane S (2012) Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 95(1):50–60. https://doi.org/10.5740/jaoacint.sge_macfarlane

    Article  CAS  PubMed  Google Scholar 

  11. Barlow GM, Yu A, Mathur R (2015) Role of the gut microbiome in obesity and diabetes mellitus. Nutr Clin Pract 30(6):787–797. https://doi.org/10.1177/0884533615609896

    Article  CAS  PubMed  Google Scholar 

  12. Xu YH, Gao CL, Guo HL, Zhang WQ, Huang W, Tang SS, Gan WJ, Xu Y, Zhou H, Zhu Q (2018) Sodium butyrate supplementation ameliorates diabetic inflammation in db/db mice. J Endocrinol 238(3):231–244. https://doi.org/10.1530/JOE-18-0137

    Article  CAS  PubMed  Google Scholar 

  13. Pussinen PJ, Havulinna AS, Lehto M, Sundvall J, Salomaa V (2011) Endotoxemia is associated with an increased risk of incident diabetes. Diabetes Care 34(2):392–397. https://doi.org/10.2337/dc10-1676

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Qin JJ, Li YR, Cai ZM, Li SH, Zhu JF, Zhang F, Liang SS, Zhang WW, Guan YL, Shen DQ, Peng YQ, Zhang DY, Jie ZY, Wu WX, Qin YW, Xue WB, Li JH, Han LC, Lu DH, Wu PX, Dai YL, Sun XJ, Li ZS, Tang AF, Zhong SL, Li XP, Chen WN, Xu R, Wang MB, Feng Q, Gong MH, Yu J, Zhang YY, Zhang M, Hansen T, Sanchez G, Raes J, Falony G, Okuda S, Almeida M, LeChatelier E, Renault P, Pons N, Batto JM, Zhang ZX, Chen H, Yang RF, Zheng WM, Li SG, Yang HM, Wang J, Ehrlich SD, Nielsen R, Pedersen O, Kristiansen K, Wang J (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490(7418):55–60. https://doi.org/10.1038/nature11450

    Article  CAS  PubMed  Google Scholar 

  15. Liu RM, Dai R, Luo Y, Xiao JH (2019) Glucose-lowering and hypolipidemic activities of polysaccharides from Cordyceps taii in streptozotocin-induced diabetic mice. BMC Complement Altern Med 19(1):230. https://doi.org/10.1186/s12906-019-2646-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Yang R, Jia Q, Liu XF, Ma SF (2018) Effect of genistein on myocardial fibrosis in diabetic rats and its mechanism. Mol Med Rep 17(2):2929–2936. https://doi.org/10.3892/mmr.2017.8268

    Article  CAS  PubMed  Google Scholar 

  17. Zhou L, Xiao X, Zhang Q, Zheng J, Deng M (2019) Maternal genistein intake mitigates the deleterious effects of high-fat diet on glucose and lipid metabolism and modulates gut microbiota in adult life of male mice. Front Physiol 10:985. https://doi.org/10.3389/fphys.2019.00985

    Article  PubMed  PubMed Central  Google Scholar 

  18. Mukund V, Mukund D, Sharma V, Mannarapu M, Alam A (2017) Genistein: Its role in metabolic diseases and cancer. Crit Rev Oncol Hematol 119:13–22. https://doi.org/10.1016/j.critrevonc.2017.09.004

    Article  PubMed  Google Scholar 

  19. Shi YN, Zhang XQ, Hu ZY, Zhang CJ, Liao DF, Huang HL, Qin L (2019) Genistein protects H9c2 cardiomyocytes against chemical hypoxia-induced injury via inhibition of apoptosis. Pharmacology 103(5–6):282–290. https://doi.org/10.1159/000497061

    Article  CAS  PubMed  Google Scholar 

  20. Gupta SK, Dongare S, Mathur R, Mohanty IR, Srivastava S, Mathur S, Nag TC (2015) Genistein ameliorates cardiac inflammation and oxidative stress in streptozotocin-induced diabetic cardiomyopathy in rats. Mol Cell Biochem 408(1–2):63–72. https://doi.org/10.1007/s11010-015-2483-2

    Article  CAS  PubMed  Google Scholar 

  21. Incir S, Bolayirli IM, Inan O, Aydin MS, Bilgin IA, Sayan I, Esrefoglu M, Seven A (2016) The effects of genistein supplementation on fructose induced insulin resistance, oxidative stress and inflammation. Life Sci 158:57–62. https://doi.org/10.1016/j.lfs.2016.06.014

    Article  CAS  PubMed  Google Scholar 

  22. Lopez P, Sanchez M, Perez-Cruz C, Velazquez-Villegas LA, Syeda T, Aguilar-Lopez M, Rocha-Viggiano AK, Del Carmen S-L, Torre-Villalvazo I, Noriega LG, Torres N, Tovar AR (2018) Long-term genistein consumption modifies gut microbiota, improving glucose metabolism, metabolic endotoxemia, and cognitive function in mice fed a high-fat diet. Mol Nutr Food Res 62(16):e1800313. https://doi.org/10.1002/mnfr.201800313

    Article  CAS  PubMed  Google Scholar 

  23. Li S, Huang Q, Zhang LW, Qiao XF, Zhang YY, Tang FS, Li ZB (2019) Effect of CAPE-pNO(2) against type 2 diabetes mellitus via the AMPK/GLUT4/GSK3β/PPARα pathway in HFD/STZ-induced diabetic mice. Eur J Pharmacol 853:1–10. https://doi.org/10.1016/j.ejphar.2019.03.027

    Article  CAS  PubMed  Google Scholar 

  24. Huang G, Xu J, Lefever DE, Glenn TC, Nagy T, Guo TL (2017) Genistein prevention of hyperglycemia and improvement of glucose tolerance in adult non-obese diabetic mice are associated with alterations of gut microbiome and immune homeostasis. Toxicol Appl Pharmacol 332:138–148. https://doi.org/10.1016/j.taap.2017.04.009

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Liu ZQ, Liu T, Chen C, Li MY, Wang ZY, Chen RS, Wei GX, Wang XY, Luo DQ (2015) Fumosorinone, a novel PTP1B inhibitor, activates insulin signaling in insulin-resistance HepG2 cells and shows anti-diabetic effect in diabetic KKAy mice. Toxicol Appl Pharmacol 285(1):61–70. https://doi.org/10.1016/j.taap.2015.03.011

    Article  CAS  PubMed  Google Scholar 

  26. Sun J, Furio L, Mecheri R, van der Does AM, Lundeberg E, Saveanu L, Chen Y, van Endert P, Agerberth B, Diana J (2015) Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota. Immunity 43(2):304–317. https://doi.org/10.1016/j.immuni.2015.07.013

    Article  CAS  PubMed  Google Scholar 

  27. Wang PC, Zhao S, Yang BY, Wang QH, Kuang HX (2016) Anti-diabetic polysaccharides from natural sources: a review. Carbohydr Polym 148:86–97. https://doi.org/10.1016/j.carbpol.2016.02.060

    Article  CAS  PubMed  Google Scholar 

  28. Behloul N, Wu G (2013) Genistein: a promising therapeutic agent for obesity and diabetes treatment. Eur J Pharmacol 698(1–3):31–38. https://doi.org/10.1016/j.ejphar.2012.11.013

    Article  CAS  PubMed  Google Scholar 

  29. Lee SR, Kwon SW, Lee YH, Kaya P, Kim JM, Ahn C, Jung EM, Lee GS, An BS, Jeung EB, Park BK, Hong EJ (2019) Dietary intake of genistein suppresses hepatocellular carcinoma through AMPK-mediated apoptosis and anti-inflammation. BMC Cancer 19(1):6. https://doi.org/10.1186/s12885-018-5222-8

    Article  PubMed  PubMed Central  Google Scholar 

  30. Matulewicz N, Karczewska-Kupczewska M (2016) Insulin resistance and chronic inflammation. Postepy Hig Med Dosw (Online) 70:1245–1258

    Google Scholar 

  31. Su Z, Nie Y, Huang X, Zhu Y, Feng B, Tang L, Zheng G (2019) Mitophagy in hepatic insulin resistance: therapeutic potential and concerns. Front Pharmacol 10:1193. https://doi.org/10.3389/fphar.2019.01193

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Jones JG (2016) Hepatic glucose and lipid metabolism. Diabetologia 59(6):1098–1103. https://doi.org/10.1007/s00125-016-3940-5

    Article  CAS  PubMed  Google Scholar 

  33. Miller RA, Birnbaum MJ (2016) Glucagon: acute actions on hepatic metabolism. Diabetologia 59(7):1376–1381. https://doi.org/10.1007/s00125-016-3955-y

    Article  CAS  PubMed  Google Scholar 

  34. Gruben N, Shiri-Sverdlov R, Koonen DP, Hofker MH (2014) Nonalcoholic fatty liver disease: a main driver of insulin resistance or a dangerous liaison? Biochim Biophys Acta 1842 11:2329–2343. https://doi.org/10.1016/j.bbadis.2014.08.004

    Article  CAS  Google Scholar 

  35. He X, Shu J, Xu L, Lu C, Lu A (2012) Inhibitory effect of Astragalus polysaccharides on lipopolysaccharide-induced TNF-α and IL-1β production in THP-1 cells. Molecules 17(3):3155–3164. https://doi.org/10.3390/molecules17033155

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Jia Q, Mehmood S, Liu X, Ma S, Yang R (2020) Hydrogen sulfide mitigates myocardial inflammation by inhibiting nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome activation in diabetic rats. Exp Biol Med (Maywood) 245(3):221–230. https://doi.org/10.1177/1535370219899899

    Article  CAS  Google Scholar 

  37. Chen X, Devaraj S (2018) Gut microbiome in obesity, metabolic syndrome, and diabetes. Curr Diabetes Rep 18(12):129. https://doi.org/10.1007/s11892-018-1104-3

    Article  CAS  Google Scholar 

  38. Upadhyaya S, Banerjee G (2015) Type 2 diabetes and gut microbiome: at the intersection of known and unknown. Gut Microbes 6(2):85–92. https://doi.org/10.1080/19490976.2015.1024918

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Bein A, Zilbershtein A, Golosovsky M, Davidov D, Schwartz B (2017) LPS induces hyper-permeability of intestinal epithelial cells. J Cell Physiol 232(2):381–390. https://doi.org/10.1002/jcp.25435

    Article  CAS  PubMed  Google Scholar 

  40. Gabele E, Dostert K, Hofmann C, Wiest R, Scholmerich J, Hellerbrand C, Obermeier F (2011) DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol 55(6):1391–1399. https://doi.org/10.1016/j.jhep.2011.02.035

    Article  CAS  PubMed  Google Scholar 

  41. Wen L, Duffy A (2017) Factors influencing the gut microbiota, inflammation, and type 2 diabetes. J Nutr 147(7):1468S-1475S. https://doi.org/10.3945/jn.116.240754

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Wu R, Zhao D, An R, Wang Z, Li Y, Shi B, Ni Q (2019) Linggui zhugan formula improves glucose and lipid levels and alters gut microbiota in high-fat diet-induced diabetic mice. Front Physiol 10:918. https://doi.org/10.3389/fphys.2019.00918

    Article  PubMed  PubMed Central  Google Scholar 

  43. Han LH, Li TG, Du M, Chang R, Zhan BY, Mao XY (2019) Beneficial effects of Potentilla discolor bunge water extract on inflammatory cytokines release and gut microbiota in high-fat diet and streptozotocin-induced type 2 diabetic mice. Nutrients 11(3):670. https://doi.org/10.3390/nu11030670

    Article  CAS  PubMed Central  Google Scholar 

  44. Hall AB, Yassour M, Sauk J, Garner A, Jiang XF, Arthur T, Lagoudas GK, Vatanen T, Fornelos N, Wilson R, Bertha M, Cohen M, Garber J, Khalili H, Gevers D, Ananthakrishnan AN, Kugathasan S, Lander ES, Blainey P, Vlamakis H, Xavier RJ, Huttenhower C (2017) A novel Ruminococcus gnavus clade enriched in inflammatory bowel disease patients. Genome Med 9(1):103. https://doi.org/10.1186/s13073-017-0490-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12(10):661–672. https://doi.org/10.1038/nrmicro3344

    Article  CAS  PubMed  Google Scholar 

  46. Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee YS, De Vadder F, Arora T, Hallen A, Martens E, Bjorck I, Backhed F (2015) Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab 22(6):971–982. https://doi.org/10.1016/j.cmet.2015.10.001

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the Natural Science Research Project of the Education Commission of Anhui Province (No. KJ2018A0994).

Author information

Authors and Affiliations

  1. Department of Physiology, Bengbu Medical College, Bengbu, 233030, China

    Rui Yang, Qiang Jia, Shanfeng Ma & Xiaofen Liu

  2. School of Life Sciences, Anhui University, Hefei, 230601, China

    Rui Yang & Shomaila Mehmood

Authors
  1. Rui Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qiang Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shomaila Mehmood
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shanfeng Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xiaofen Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiang Jia.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, R., Jia, Q., Mehmood, S. et al. Genistein ameliorates inflammation and insulin resistance through mediation of gut microbiota composition in type 2 diabetic mice. Eur J Nutr 60, 2155–2168 (2021). https://doi.org/10.1007/s00394-020-02403-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00394-020-02403-0

Keywords

Search

Navigation